Shandong Dongyue Organosilicon Materials Co., Ltd. (SHE:300821)
China · Delayed Price · Currency is CNY 14.88
-0.41 (-2.68%)
Sep 4, 2026, 3:04 PM CST
SHE:300821 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 4,009 | 3,672 | 5,066 | 4,745 | 6,647 | 4,268 |
Other Revenue | 98.49 | 98.49 | 84.99 | 56.37 | 87.23 | 65.09 |
| 4,108 | 3,770 | 5,151 | 4,801 | 6,734 | 4,333 | |
Revenue Growth | -13.35% | -26.80% | 7.27% | -28.70% | 55.40% | 73.10% |
Cost of Revenue | 3,483 | 3,604 | 4,840 | 4,805 | 5,827 | 2,723 |
Gross Profit | 624.35 | 166.56 | 310.78 | -3.88 | 906.97 | 1,610 |
Selling, General & Admin | 67.79 | 69.04 | 64.44 | 72.97 | 87.72 | 77.53 |
Research & Development | 141.38 | 133.35 | 164.16 | 233.53 | 316.58 | 231.82 |
Other Operating Expenses | -10.35 | -20.76 | -10.07 | 5.71 | 11.51 | 11.1 |
Operating Expenses | 198.52 | 181.34 | 219.64 | 312.01 | 415.83 | 321.51 |
Operating Income | 425.84 | -14.78 | 91.14 | -315.89 | 491.14 | 1,289 |
Interest Expense | - | - | - | -0.02 | -0.08 | -0.13 |
Interest & Investment Income | 8.79 | 9.93 | 10.92 | 18.95 | 30.26 | 42.96 |
Currency Exchange Gain (Loss) | 4.22 | 4.22 | 5.9 | -2.27 | 27.92 | -7.48 |
Other Non Operating Income (Expenses) | -56.04 | -0.77 | -1.09 | -1.01 | -5.81 | -1.37 |
EBT Excluding Unusual Items | 382.81 | -1.4 | 106.87 | -300.25 | 543.43 | 1,323 |
Gain (Loss) on Sale of Assets | - | -0.01 | -0.27 | 0.02 | 0.14 | -4.18 |
Asset Writedown | -21.04 | -28.68 | -39.26 | -4.03 | -6.18 | -15.11 |
Other Unusual Items | 10.5 | 10.5 | 5.55 | 4.78 | 4.59 | 10.84 |
Pretax Income | 372.28 | -19.59 | 72.89 | -298.99 | 542 | 1,315 |
Income Tax Expense | 5.26 | - | 20.06 | -27.43 | 31.01 | 164.05 |
Earnings From Continuing Operations | 367.03 | -19.59 | 52.83 | -271.56 | 510.98 | 1,151 |
Minority Interest in Earnings | 0.25 | 0.28 | 3.93 | 0.43 | 0.14 | - |
Net Income | 367.28 | -19.31 | 56.76 | -271.12 | 511.12 | 1,151 |
Net Income to Common | 367.28 | -19.31 | 56.76 | -271.12 | 511.12 | 1,151 |
Net Income Growth | 988.61% | - | - | - | -55.58% | 309.87% |
Shares Outstanding (Basic) | 1,034 | 965 | 1,135 | 1,179 | 1,189 | 1,199 |
Shares Outstanding (Diluted) | 1,034 | 965 | 1,135 | 1,179 | 1,189 | 1,199 |
Shares Change | 2.28% | -14.95% | -3.70% | -0.83% | -0.83% | 6.74% |
EPS (Basic) | 0.36 | -0.02 | 0.05 | -0.23 | 0.43 | 0.96 |
EPS (Diluted) | 0.36 | -0.02 | 0.05 | -0.23 | 0.43 | 0.96 |
EPS Growth | 964.31% | - | - | - | -55.21% | 284.00% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 179.65 | 193.78 | 199.64 | -368.24 | -438.45 | -568.36 |
Free Cash Flow Per Share | 0.17 | 0.20 | 0.18 | -0.31 | -0.37 | -0.47 |
Dividend Per Share | 0.020 | 0.020 | 0.015 | - | 0.100 | 0.380 |
Dividend Growth | 33.33% | 33.33% | - | - | -73.68% | 204.00% |
Gross Margin | 15.20% | 4.42% | 6.03% | -0.08% | 13.47% | 37.16% |
Operating Margin | 10.37% | -0.39% | 1.77% | -6.58% | 7.29% | 29.74% |
Profit Margin | 8.94% | -0.51% | 1.10% | -5.65% | 7.59% | 26.55% |
Free Cash Flow Margin | 4.37% | 5.14% | 3.88% | -7.67% | -6.51% | -13.12% |
EBITDA | 808.71 | 359.17 | 446.53 | 13.83 | 755.42 | 1,406 |
EBITDA Margin | 19.69% | 9.53% | 8.67% | 0.29% | 11.22% | 32.45% |
D&A For EBITDA | 382.87 | 373.95 | 355.4 | 329.72 | 264.28 | 117.28 |
EBIT | 425.84 | -14.78 | 91.14 | -315.89 | 491.14 | 1,289 |
EBIT Margin | 10.37% | -0.39% | 1.77% | -6.58% | 7.29% | 29.74% |
Effective Tax Rate | 1.41% | - | 27.52% | - | 5.72% | 12.48% |
Revenue as Reported | 3,770 | 3,770 | 5,151 | 4,801 | 6,734 | 4,333 |